MetaADEDB 2.0 @ LMMD
benazeprilat
(MADRIHWFJGRSBP-ROUUACIJSA-N)
Structure
SMILES
OC(=O)CN1C(=O)[C@H](CCc2c1cccc2)N[C@H](C(=O)O)CCc1ccccc1
Type(s)
Experimental
Molecular Formula:
C22H24N2O5
Molecular Weight:
396.436
Log P:
2.5505
Hydrogen Bond Acceptor:
7
Hydrogen Bond Donor:
3
TPSA:
106.94
CAS Number(s):
86541-78-8
Synonym(s)
1.
benazeprilat
2.
CGS 14831
3.
CGS-14831
4.
benezaprilat
External Link(s)
MeSHC052133
PubChem Compound5463984
BindingDB50021127
ChEBI88200
CHEMBLCHEMBL1192519
DrugBankDB14125
IUPHAR/BPS Guide to PHARMACOLOGY6375
KEGGcpd:C21541
dr:D03077
ZINC3814184
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1AgranulocytosisSIDER
2AlopeciaSIDER
3Anaphylactic shockSIDER
4Anaphylactoid ReactionSIDER
5Angina PectorisSIDER
6AnxietySIDER
7ArthralgiaSIDER
8ArthritisSIDER
9AstheniaSIDER
10AsthmaSIDER
11Blood creatinine increasedSIDER
12Blood urea increasedSIDER
13BronchitisSIDER
14ConstipationSIDER
15DermatitisSIDER
16Disturbance in sexual arousalSIDER
17DizzinessSIDER
18Electrocardiogram changeSIDER
19EosinophiliaSIDER
20Erectile dysfunctionSIDER
21Erythema MultiformeSIDER
22FatigueSIDER
23FlushingSIDER
24GastritisSIDER
25HeadacheSIDER
26HypersensitivitySIDER
27Hypotension symptomaticSIDER
28HypotensionSIDER
29InfectionSIDER
30LeukopeniaSIDER
31Musculoskeletal discomfortSIDER
32MyalgiaSIDER
33NauseaSIDER
34NervousnessSIDER
35NeutropeniaSIDER
36PalpitationsSIDER
37PancreatitisSIDER
38PemphigusSIDER
39Protein urine presentSIDER
40ProteinuriaSIDER
41PruritusSIDER
42Pulmonary EosinophiliaSIDER
43ShockSIDER
44SinusitisSIDER
45Small bowel angioedemaSIDER
46SomnolenceSIDER
47Stevens-Johnson SyndromeSIDER
48SweatingSIDER
49SyncopeSIDER
50TensionSIDER
51ThrombocytopeniaSIDER
52Urinary tract infectionSIDER
53VomitingSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.